HBM HOLDINGS-B (02142) Exercises Warrants Under Authorization and Cooperation Agreement with Spruce

Stock News01-19

HBM HOLDINGS-B (02142) announced details regarding the authorization and cooperation agreement entered into by its incubated innovative biotech company, HBM Alpha Therapeutics (HBMAT), with Spruce Biosciences Inc. (Spruce). The agreement aims to advance novel corticotropin-releasing hormone (CRH) targeted therapies for a variety of diseases. Under this agreement, HBMAT and its affiliates were granted warrants providing rights to acquire a minority equity stake in Spruce through the purchase of its common stock. On January 19, 2026, the company and HBMAT exercised these warrants in accordance with the agreement. Following the exercise, the company holds approximately 3.8% of Spruce's total issued shares and about 3.1% of Spruce's fully diluted shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180132956?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-19 08:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180132956","market":"sh","top_or_hot":-1,"title":"HBM HOLDINGS-B (02142) Exercises Warrants Under Authorization and Cooperation Agreement with Spruce","media":"Stock News","content":"<p>HBM HOLDINGS-B (02142) announced details regarding the authorization and cooperation agreement entered into by its incubated innovative biotech company, HBM Alpha Therapeutics (HBMAT), with Spruce Biosciences Inc. (Spruce). The agreement aims to advance novel corticotropin-releasing hormone (CRH) targeted therapies for a variety of diseases. Under this agreement, HBMAT and its affiliates were granted warrants providing rights to acquire a minority equity stake in Spruce through the purchase of its common stock. On January 19, 2026, the company and HBMAT exercised these warrants in accordance with the agreement. Following the exercise, the company holds approximately 3.8% of Spruce's total issued shares and about 3.1% of Spruce's fully diluted shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HBM HOLDINGS-B (02142) Exercises Warrants Under Authorization and Cooperation Agreement with Spruce</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHBM HOLDINGS-B (02142) Exercises Warrants Under Authorization and Cooperation Agreement with Spruce\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-19 08:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HBM HOLDINGS-B (02142) announced details regarding the authorization and cooperation agreement entered into by its incubated innovative biotech company, HBM Alpha Therapeutics (HBMAT), with Spruce Biosciences Inc. (Spruce). The agreement aims to advance novel corticotropin-releasing hormone (CRH) targeted therapies for a variety of diseases. Under this agreement, HBMAT and its affiliates were granted warrants providing rights to acquire a minority equity stake in Spruce through the purchase of its common stock. On January 19, 2026, the company and HBMAT exercised these warrants in accordance with the agreement. Following the exercise, the company holds approximately 3.8% of Spruce's total issued shares and about 3.1% of Spruce's fully diluted shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和铂医药-B","start_time":0,"source_url":"","article_id":"1180132956","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180132956","pubTimestamp":1768781651,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"HBM HOLDINGS-B (02142) announced details regarding the authorization and cooperation agreement entered into by its incubated innovative biotech company, HBM Alpha Therapeutics (HBMAT), with Spruce...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02142":"和铂医药-B","BK1583":"高瓴概念","BK1161":"生物科技","BK1574":"生物医药B类股"},"translate_title":"HBM HOLDINGS-B(02142)根据与Spruce的授权及合作协议行使认股权证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":1},"content_text":"HBM HOLDINGS-B (02142) announced details regarding the authorization and cooperation agreement entered into by its incubated innovative biotech company, HBM Alpha Therapeutics (HBMAT), with Spruce Biosciences Inc. (Spruce). The agreement aims to advance novel corticotropin-releasing hormone (CRH) targeted therapies for a variety of diseases. Under this agreement, HBMAT and its affiliates were granted warrants providing rights to acquire a minority equity stake in Spruce through the purchase of its common stock. On January 19, 2026, the company and HBMAT exercised these warrants in accordance with the agreement. Following the exercise, the company holds approximately 3.8% of Spruce's total issued shares and about 3.1% of Spruce's fully diluted shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180132956","isCrawlerRequest":true}